辉诺医药

Biotech/Healthcare

Huino Pharma, founded in December 2018 in Hangzhou, is a clinical-stage innovative company focused on the development of new anti-infective drugs. Its core management team has spent decades researching infectious diseases and has extensive international drug development experience.

Latest round: Series A Extension (2021)